Angiogenic Growth Factor and Revascularization of the Ischemic Limb: Evaluation in a Rabbit Model

Lee Li-Qun Pu, Allan D. Sniderman, Zaid Arekat, Alan M. Graham, Roland Brassard, James F. Symes

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

We have previously shown that administration of endothelial cell growth factor (ECGF) significantly accelerates revascularization in the ischemic rabbit hindlimb model. Nevertheless, much remains to be learned as to the effectiveness and limitations of this approach. The present study was designed, therefore, to determine whether a dose-response relationship could be demonstrated for this agent, whether it was effective if systemically administered, and finally, whether it affected vascularization in a nonischemic limb. Our established unilateral ischemic rabbit hindlimb model and ECGF administration protocol were used to examine these questions. Three groups of animals were studied to determine a dose-response relationship of ECGF in the ischemic limb. Revascularization was assessed by measurement of calf blood left to right (L/R) pressure ratio before (Day 0) and after ECGF injections (Days 1, 10, and 20) and quantitative vascularization was assessed by angiography at Day 20 when the study was terminated. Two other groups of animals were also studied. In Group 4, intramuscular ECGF was injected in the left front limb remote from the ischemic hindlimb and in Group 5 it was injected into the left hindlimb of a normal animal. In neither group was any significant effect on vascularization evident. Thus, our data suggest that the relationship of ECGF and revascularization of the ischemic limb is dose dependent and is demonstrable only when it is administered directly into the limb in the presence of ischemia.

Original languageEnglish (US)
Pages (from-to)575-583
Number of pages9
JournalJournal of Surgical Research
Volume54
Issue number6
DOIs
StatePublished - Jun 1993
Externally publishedYes

Fingerprint

Endothelial Growth Factors
Angiogenesis Inducing Agents
Intercellular Signaling Peptides and Proteins
Extremities
Endothelial Cells
Hindlimb
Rabbits
Angiography
Ischemia
Pressure
Injections

ASJC Scopus subject areas

  • Surgery

Cite this

Angiogenic Growth Factor and Revascularization of the Ischemic Limb : Evaluation in a Rabbit Model. / Pu, Lee Li-Qun; Sniderman, Allan D.; Arekat, Zaid; Graham, Alan M.; Brassard, Roland; Symes, James F.

In: Journal of Surgical Research, Vol. 54, No. 6, 06.1993, p. 575-583.

Research output: Contribution to journalArticle

Pu, Lee Li-Qun ; Sniderman, Allan D. ; Arekat, Zaid ; Graham, Alan M. ; Brassard, Roland ; Symes, James F. / Angiogenic Growth Factor and Revascularization of the Ischemic Limb : Evaluation in a Rabbit Model. In: Journal of Surgical Research. 1993 ; Vol. 54, No. 6. pp. 575-583.
@article{5151514a3aac4c058ee9df17cfc8ee43,
title = "Angiogenic Growth Factor and Revascularization of the Ischemic Limb: Evaluation in a Rabbit Model",
abstract = "We have previously shown that administration of endothelial cell growth factor (ECGF) significantly accelerates revascularization in the ischemic rabbit hindlimb model. Nevertheless, much remains to be learned as to the effectiveness and limitations of this approach. The present study was designed, therefore, to determine whether a dose-response relationship could be demonstrated for this agent, whether it was effective if systemically administered, and finally, whether it affected vascularization in a nonischemic limb. Our established unilateral ischemic rabbit hindlimb model and ECGF administration protocol were used to examine these questions. Three groups of animals were studied to determine a dose-response relationship of ECGF in the ischemic limb. Revascularization was assessed by measurement of calf blood left to right (L/R) pressure ratio before (Day 0) and after ECGF injections (Days 1, 10, and 20) and quantitative vascularization was assessed by angiography at Day 20 when the study was terminated. Two other groups of animals were also studied. In Group 4, intramuscular ECGF was injected in the left front limb remote from the ischemic hindlimb and in Group 5 it was injected into the left hindlimb of a normal animal. In neither group was any significant effect on vascularization evident. Thus, our data suggest that the relationship of ECGF and revascularization of the ischemic limb is dose dependent and is demonstrable only when it is administered directly into the limb in the presence of ischemia.",
author = "Pu, {Lee Li-Qun} and Sniderman, {Allan D.} and Zaid Arekat and Graham, {Alan M.} and Roland Brassard and Symes, {James F.}",
year = "1993",
month = "6",
doi = "10.1006/jsre.1993.1088",
language = "English (US)",
volume = "54",
pages = "575--583",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Angiogenic Growth Factor and Revascularization of the Ischemic Limb

T2 - Evaluation in a Rabbit Model

AU - Pu, Lee Li-Qun

AU - Sniderman, Allan D.

AU - Arekat, Zaid

AU - Graham, Alan M.

AU - Brassard, Roland

AU - Symes, James F.

PY - 1993/6

Y1 - 1993/6

N2 - We have previously shown that administration of endothelial cell growth factor (ECGF) significantly accelerates revascularization in the ischemic rabbit hindlimb model. Nevertheless, much remains to be learned as to the effectiveness and limitations of this approach. The present study was designed, therefore, to determine whether a dose-response relationship could be demonstrated for this agent, whether it was effective if systemically administered, and finally, whether it affected vascularization in a nonischemic limb. Our established unilateral ischemic rabbit hindlimb model and ECGF administration protocol were used to examine these questions. Three groups of animals were studied to determine a dose-response relationship of ECGF in the ischemic limb. Revascularization was assessed by measurement of calf blood left to right (L/R) pressure ratio before (Day 0) and after ECGF injections (Days 1, 10, and 20) and quantitative vascularization was assessed by angiography at Day 20 when the study was terminated. Two other groups of animals were also studied. In Group 4, intramuscular ECGF was injected in the left front limb remote from the ischemic hindlimb and in Group 5 it was injected into the left hindlimb of a normal animal. In neither group was any significant effect on vascularization evident. Thus, our data suggest that the relationship of ECGF and revascularization of the ischemic limb is dose dependent and is demonstrable only when it is administered directly into the limb in the presence of ischemia.

AB - We have previously shown that administration of endothelial cell growth factor (ECGF) significantly accelerates revascularization in the ischemic rabbit hindlimb model. Nevertheless, much remains to be learned as to the effectiveness and limitations of this approach. The present study was designed, therefore, to determine whether a dose-response relationship could be demonstrated for this agent, whether it was effective if systemically administered, and finally, whether it affected vascularization in a nonischemic limb. Our established unilateral ischemic rabbit hindlimb model and ECGF administration protocol were used to examine these questions. Three groups of animals were studied to determine a dose-response relationship of ECGF in the ischemic limb. Revascularization was assessed by measurement of calf blood left to right (L/R) pressure ratio before (Day 0) and after ECGF injections (Days 1, 10, and 20) and quantitative vascularization was assessed by angiography at Day 20 when the study was terminated. Two other groups of animals were also studied. In Group 4, intramuscular ECGF was injected in the left front limb remote from the ischemic hindlimb and in Group 5 it was injected into the left hindlimb of a normal animal. In neither group was any significant effect on vascularization evident. Thus, our data suggest that the relationship of ECGF and revascularization of the ischemic limb is dose dependent and is demonstrable only when it is administered directly into the limb in the presence of ischemia.

UR - http://www.scopus.com/inward/record.url?scp=0027435139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027435139&partnerID=8YFLogxK

U2 - 10.1006/jsre.1993.1088

DO - 10.1006/jsre.1993.1088

M3 - Article

C2 - 7692132

AN - SCOPUS:0027435139

VL - 54

SP - 575

EP - 583

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 6

ER -